Cardiovascular and cardiometabolic prevention: high-level priority in the era of COVID-19.
作者信息
Dhindsa Devinder, Wong Nathan D, Sperling Laurence
机构信息
Division of Cardiology, Department of Medicine, Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, Georgia.
Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, California, USA.
出版信息
Cardiovasc Endocrinol Metab. 2020 Jun 11;9(3):125-127. doi: 10.1097/XCE.0000000000000215. eCollection 2020 Sep.
Abstract
摘要
相似文献
1
Cardiovascular and cardiometabolic prevention: high-level priority in the era of COVID-19.心血管与心脏代谢预防：新冠疫情时代的高度优先事项
Cardiovasc Endocrinol Metab. 2020 Jun 11;9(3):125-127. doi: 10.1097/XCE.0000000000000215. eCollection 2020 Sep.
2
Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19.心血管代谢性共病和种族对 COVID-19 患者心血管/肾脏并发症的影响。
Heart. 2022 Jul 13;108(15):1200-1208. doi: 10.1136/heartjnl-2021-320047.
3
Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study.大流行期间患有心脏代谢疾病且无 COVID-19 证据的门诊患者。CorCOVID LATAM 研究。
Glob Heart. 2021 Feb 17;16(1):15. doi: 10.5334/gh.932.
4
5
Cardiometabolic disease and multiple long-term condition healthcare provision in Sub-Saharan Africa: Opportunities for new models of care in the post-COVID era.撒哈拉以南非洲地区的心脏代谢疾病和多种长期疾病医疗服务：后新冠时代新型护理模式的机遇
Diabetes Metab Syndr. 2023 Jan;17(1):102681. doi: 10.1016/j.dsx.2022.102681. Epub 2022 Dec 5.
6
The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases.基因组学、转录组学、表观遗传学和代谢组学生物标志物在 2 型糖尿病和心血管疾病个体化预防中的前景。
Curr Vasc Pharmacol. 2023;21(3):185-196. doi: 10.2174/1570161121666230510141338.
7
A network meta-analysis of association between cardiometabolic risk factors and COVID-19 outcome severity.一项关于心血管代谢风险因素与 COVID-19 结局严重程度关联的网络荟萃分析。
J Diabetes. 2023 Nov;15(11):968-977. doi: 10.1111/1753-0407.13445. Epub 2023 Aug 30.
8
Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk: A 2-Sample Mendelian Randomization Study.与高心血管代谢风险人群中重症 COVID-19 相关的生物标志物：两样本 Mendelian 随机研究。
JAMA Netw Open. 2023 Jul 3;6(7):e2325914. doi: 10.1001/jamanetworkopen.2023.25914.
9
Coronavirus Disease 2019 and Cardiometabolic Disease.新型冠状病毒肺炎与心血管代谢疾病。
Cardiol Rev. 2022;30(3):123-128. doi: 10.1097/CRD.0000000000000405.
10
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II).心血管代谢性多重合并症与比单个心血管代谢风险因素更差的 Covid-19 预后相关：一项多中心回顾性研究（CoViDiab II）。
Cardiovasc Diabetol. 2020 Oct 1;19(1):164. doi: 10.1186/s12933-020-01140-2.
引用本文的文献
1
Biomarkers of glucose homeostasis as mediators of the relationship of body mass index and waist circumference with COVID-19 outcomes among postmenopausal women: The Women's Health Initiative.葡萄糖稳态生物标志物作为体重指数和腰围与绝经后妇女 COVID-19 结局关系的中介：妇女健康倡议。
Clin Nutr. 2023 Sep;42(9):1690-1700. doi: 10.1016/j.clnu.2023.07.004. Epub 2023 Jul 23.
2
Determinants of COVID-19 Outcome as Predictors of Delayed Healthcare Services among Adults ≥50 Years during the Pandemic: 2006-2020 Health and Retirement Study.COVID-19 结局的决定因素预测了疫情期间 50 岁及以上成年人延迟医疗服务的情况：2006-2020 年健康与退休研究。
Int J Environ Res Public Health. 2022 Sep 23;19(19):12059. doi: 10.3390/ijerph191912059.
3
Address Changes Are Associated With Unmet Glycemic Targets: Opportunities to Improve Processes and Outcomes of Care Among People With Type 2 Diabetes.地址变更与血糖控制目标未达标相关：改善 2 型糖尿病患者护理流程和结局的机会。
Perm J. 2022 Jun 29;26(2):1-10. doi: 10.7812/TPP/21.144. Epub 2022 Jun 15.
4
Socio-demographic, lifestyle and health characteristics as predictors of self-reported Covid-19 history among older adults: 2006-2020 Health and Retirement Study.社会人口统计学、生活方式和健康特征对老年人自报的 Covid-19 病史的预测作用：2006-2020 年健康与退休研究。
Am J Infect Control. 2022 May;50(5):482-490. doi: 10.1016/j.ajic.2022.02.021. Epub 2022 Mar 12.
5
Predictors of mortality in hospitalized COVID-19 patients: A Mexican population-based cohort study.住院COVID-19患者的死亡率预测因素：一项基于墨西哥人群的队列研究。
Biomedicine (Taipei). 2021 Jun 1;11(2):1-4. doi: 10.37796/2211-8039.1124. eCollection 2021.
6
Race and gender differences in abnormal blood glucose screening and clinician response to prediabetes: A mixed-methods assessment.种族和性别差异对异常血糖筛查和临床医生对糖尿病前期的反应：一项混合方法评估。
Prev Med. 2021 Jul;148:106587. doi: 10.1016/j.ypmed.2021.106587. Epub 2021 Apr 27.
7
Introduction: cardiometabolic considerations in COVID-19.引言：2019冠状病毒病中的心脏代谢相关考量
Cardiovasc Endocrinol Metab. 2020 Jul 27;9(3):101. doi: 10.1097/XCE.0000000000000225. eCollection 2020 Sep.
本文引用的文献
1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病（COVID-19）疫情的流行病学特征 - 中国，2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.心血管疾病、药物治疗与新冠病毒感染相关死亡率
N Engl J Med. 2020 Jun 18;382(25):e102. doi: 10.1056/NEJMoa2007621. Epub 2020 May 1.
3
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
4
Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?脂肪组织是否是 2019 年冠状病毒病病毒传播、免疫激活和细胞因子扩增的储库？
Obesity (Silver Spring). 2020 Jul;28(7):1191-1194. doi: 10.1002/oby.22843. Epub 2020 May 31.
5
Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission.60岁以下患者的肥胖是COVID-19住院治疗的一个风险因素。
Clin Infect Dis. 2020 Jul 28;71(15):896-897. doi: 10.1093/cid/ciaa415.
6
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.2019 年冠状病毒病患者中某些基础健康状况的初步估计——美国，2020 年 2 月 12 日至 3 月 28 日。
MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Prevalence of Obesity Among Adults and Youth: United States, 2015-2016.2015 - 2016年美国成年人及青少年肥胖症患病率
NCHS Data Brief. 2017 Oct(288):1-8.
Zotero 插件